Obese youth with leukemia more likely to have persistent disease

27 octubre 2014

Following induction chemotherapy, obese patients were more than twice as likely to have minimal residual disease, than non-obese patients, new research suggests. «Induction chemotherapy provides a patient’s best chance for remission or a cure,» said the principal investigator. «Our findings indicate that a patient’s obesity negatively impacts the ability of chemotherapy to kill leukemia cells, reducing the odds of survival.»